A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects with Hematologic Malignancies following Myeloablative TherapyEstudio de control de cohortes histórico, internacional y multicéntrico para la evaluación de la eficacia y seguridad del transplante de StemEx®, hemocitoblastos de cordón umbilical y células progenitoras expandidas ex vivo, en pacientes que padecen neoplasias hematológicas, a continuación del tratamiento mielosupresor - ExCell
A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx®, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects With Hematologic Malignancies Following Myeloablative Therapy
The purpose of this study is to determine the efficacy and safety of transplanting StemEx® in patients with certain hematological malignancies. For these patients, it is suggested that StemEx® can improve upon the outcome of transplanting a single, unmanipulated cord blood unit by significantly increasing the number of stem/progenitor cells available to the patient.
100 项与 Gamida Cell -Teva Joint Venture Ltd. 相关的临床结果
0 项与 Gamida Cell -Teva Joint Venture Ltd. 相关的专利（医药）
100 项与 Gamida Cell -Teva Joint Venture Ltd. 相关的药物交易
100 项与 Gamida Cell -Teva Joint Venture Ltd. 相关的转化医学
